(19)
(11) EP 0 840 787 A2

(12)

(43) Date of publication:
13.05.1998 Bulletin 1998/20

(21) Application number: 96945463.0

(22) Date of filing: 20.06.1996
(51) International Patent Classification (IPC): 
G01N 33/ 53( . )
A61K 45/ 00( . )
A61P 29/ 00( . )
C07K 16/ 28( . )
C12N 1/ 21( . )
C12N 15/ 09( . )
C12P 21/ 02( . )
G01N 33/ 566( . )
A61K 38/ 00( . )
A61K 48/ 00( . )
C07K 14/ 705( . )
C12N 1/ 19( . )
C12N 5/ 10( . )
C12N 15/ 12( . )
C12P 21/ 08( . )
(86) International application number:
PCT/US1996/010618
(87) International publication number:
WO 1997/000952 (09.01.1997 Gazette 1997/03)
(84) Designated Contracting States:
BE DE ES FR GB IT NL

(30) Priority: 20.06.1995 US 19950000352P
06.12.1995 US 19950567817

(71) Applicant: INCYTE PHARMACEUTICALS, INC.
Palo Alto , CA 94304 (US)

(72) Inventor:
  • SEILHAMER, Jeffrey J.
    Los Altos Hills, CA 94022 (US)

(74) Representative: Wright, Simon Mark 
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) A HUMAN EDG-2 RECEPTOR HOMOLOG